WVE Q2 2024 Earnings — Wave Life Sciences Ltd. Revenue & Financial Results | Market Cap Arena

WVEWave Life Sciences Ltd.

$3B

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M-10.9% YoY

Gross Profit

$20M100.0% margin

Operating Income

-$35M-177.7% margin

Net Income

-$33M-167.2% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+57.1%

Cash Flow

Operating Cash Flow

-$27M

Free Cash Flow

-$28M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$209M

Total Liabilities

$204M

Stockholders' Equity

$4M

Cash & Equivalents

$154M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$22M	-10.9%
Gross Profit	$20M	-$11M	+275.7%
Operating Income	-$35M	-$23M	-49.1%
Net Income	-$33M	-$21M	-56.0%